To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

August 02, 2019___

Today's Rundown

Featured Story

Rakuten Medical reels in another megaround to fund cancer R&D

Rakuten Medical has raised $100 million to advance its pipeline of photoimmunotherapy oncology prospects. The biotech hopes to use antibodies and light to destroy cancer cells while leaving healthy tissues unharmed. 

Top Stories

Phase 3 trial of Transgene's oncolytic virus halted for futility

A phase 3 liver cancer trial of Transgene and SillaJen’s oncolytic virus has been stopped early for futility. The setback sent the share prices of the companies downward and added to doubts about the effectiveness of oncolytic viruses. 

BioMarin drops lower dose of its hemophilia gene therapy as it eyes submissions by year-end

In its race to be the first to submit a gene therapy for review in hemophilia, BioMarin is dropping development of a lower dose of its valrox treatment, amid plans to get its applications into the hands of regulators before the end of the year.

Freezing your T cells today for potential CAR-T therapies tomorrow

A company offering to freeze donors’ T cells and save them until the day they are needed—perhaps even years before the onset of cancer or disease—is getting off the ground with $1 million in funding.

EuroBiotech Report—R&D execs leave Adaptimmune and Zealand, Wellington fund, Gilead and Woodford

In this week's EuroBiotech Report, Adaptimmune, Zealand suffer senior R&D departures, Wellington raises fund and Gilead talks up Galapagos deal.

FiercePharmaAsia—Takeda's cost-saving progress; Dr. Reddy's shortfall; Strides' China JV

Takeda is making progress on its cost-saving plans. The U.S. FDA cited Dr. Reddy's for manufacturing shortfalls in a Form 483. Following its Indian pharma peers, Strides Pharma entered China through a JV with Sihuan Pharma. And more.

Chutes & Ladders—Mylan CEO Bresch to exit company after Upjohn merger

Mylan CEO Bresch set to retire after merger with Pfizer spinoff Upjohn; Adaptimmune CSO leaving to "pursue other opportunities"; Verastem pegs Stuglik as next head honcho.

Resources

[Whitepaper] Flow Chemistry: A Scale-up Solution for Modern API Development and Manufacturing

Patheon, part of Thermo Fisher Scientific, offers advanced API manufacturing technologies such as continuous processing and continuous analytics to deliver high-quality products with well-defined features to meet your timelines and volume requirements.

[Whitepaper] The Impact of Artificial Intelligence on Outcomes Based Contracting

Understanding the challenges for formulary decision makers and manufacturers.

[Whitepaper] How Vertex Cut Database Build Timelines by 50%

This white paper details how leveraging new reporting capabilities, live UAT feedback sessions, and an agile design approach to study builds will save them time and money.

[Whitepaper] The Truth about Physician Referrals and Clinical Trials

The Study Voices survey challenges the myth that physicians won’t refer patients to clinical trials, and it identifies opportunities to engage physicians as partners in the enrollment process.

[eBook] Small molecules 2.0: the bigger picture

The highest number of NCEs approved by the FDA…the fastest growing small molecule clinical pipeline reported in 20 years…these are exciting times for our industry.

[Paid Marketplace] Faster Research. Smarter Bibliographies.

Cut your research time in half - with an easy-to-use app for scientists that combines full-featured reference management with integrated search and on-demand document delivery.

[Video] Almac Launches Almac Adapt™ - a New Patient-Centric Supply Solution

Innovative Just in Time Manufacturing solution enables sponsors full late stage customisation of clinical trial materials

[Video] PwC Webcast: Goodbye cost shifting, hello employer activism

How are employer activism strategies beginning to replace the cost-sharing of the past, and improve the health of the workforce?

[Whitepaper] IoT Technologies & Informatics Integration in Pharmaceuticals

Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies.

[Report] NEW Report on 2019 e-Prescribing Regulations and Potential Impact

Patient demand for more information on their care is driving new e-prescribing regulations, and technology is evolving to help providers meet them. This report provides an overview of key areas where such regulation has emerged, and what it could mean for providers and healthcare IT companies.

[Case Study] Clinical Supply Management

Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study.

[Video] Demand Led Services and Clinical Supply Efficiency

Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels.

[eBook] Strategies for Efficient Clinical Supply Management and Forecasting

Download the eBook to explore a proactive approach for clinical supply management.

Events